No Data
No Data
No Data
No Data
No Data
Are TG Therapeutics, Inc.'s (NASDAQ:TGTX) Mixed Financials Driving The Negative Sentiment?
With its stock down 11% over the past three months, it is easy to disregard TG Therapeutics (NASDAQ:TGTX). It is possible that the markets have ignored the company's differing financials and decided
Simply Wall StApr 24 09:13 ET
Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)
TipRanksApr 23 09:38 ET
Sector Update: Health Care
Health care stocks were mixed late Thursday afternoon with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%. The iShares Biotechnology ETF (IBB) fell
MT NewswiresApr 18 15:38 ET
TG Therapeutics Price Target Maintained With a $25.00/Share by JP Morgan
TG Therapeutics Price Target Maintained With a $25.00/Share by JP Morgan
Dow JonesApr 18 13:40 ET
Express News | Ladenburg Thalmann Reiterates Buy on TG Therapeutics, Maintains $39 Price Target
Moomoo 24/7Apr 18 13:27 ET
TG Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/18/2024 170.27% Ladenburg Thalmann → $39 Reiterates Buy → Buy 03/01/2024 211.85% HC Wainwright & Co. →
BenzingaApr 18 13:25 ET
No Data
No Data